pBI-11 (3 doses) for papillomavirus infections

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Jan 2024: Trial registered, NCT06210854
  2. 25 Jun 2026: Trial started, NCT06210854

The trials

NCT06210854: Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+

State
Under way
Phase
Phase 2
People
48 planned
Started
25 Jun 2026
Primary completion
Nov 2028
Arms
Arm 1: pBI-11 + pBI-11 + pBI-11
Results
None posted
  1. 18 Jan 2024: Trial registered
  2. 25 Jun 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.